• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Latest

The Bear Conspiracy Pt.2: Not out of the woods…yet

Like 0

By Lachlann Tierney, Tuesday, 25 November 2025

Speculative ASX stocks may have found a floor. It’s time for cautious optimism near-term, and a look these four sectors going into 2026.

Is it over?

One glance through the gap between my fingers shows almost all green on the small-cap watchlist. Almost all green in micro-cap land too.

But we’re not quite there yet for the more speculative parts of the market.

Yesterday I pointed out surging US biotech indices and ETFs. These suggest the AI bubble panic was more about big funds shifting the media narrative in order to re-position.

I took specific umbrage with Ray Dalio.

I think he runs a cynical but also shrewd spin machine based on a cult of personality. And the returns have been great for his ~US$135BN Bridgewater.

But you should keep your eye on the ball. The larger point is about what is beyond the headlines and your internal psychology.

Speaking of THE headline…

All eyes were on the Nvidia earnings release last week.

Good results caused a pump, a sudden dump and then an eerie calm edge up.

I watched the numbers come in live like a hawk because market psychology is a self-fulfilling prophecy.

If people think it’s important it becomes important. After all, it certainly moves prices.

Technical analysis is sometimes dismissed as woo-woo astrology.

But it helps define a narrative – it’s effectively a massive map of the psychology of an asset’s value over time.

So, if the smaller side of the market interests you, the chart below is the one to watch.

The XEC tells the story

If you like small-caps and micro-caps then the ASX Emerging Companies Index remains a good barometer for the health of these parts of the market.

We had a top in 2022. Three years in a barren tundra of sad capital raises. An almighty 63% run up from the April tariff mini-panic.

And now a 15% retracement is taking us back to where we were at the start of 2022.

Source: TradingView

[Click to open in a new window]

This reads to me as the market cooling off, not collapsing. More like a half time break than the final whistle.

What’s next for risk capital?

I reckon rare earths and Aussie real estate exposures have had their run for now.

When China slapped export restrictions on rare earths in April as retaliation for Trump’s tariffs, ASX rare earth miners went ballistic. Some names ran 100% to 380% in weeks.

That was the speculative frenzy since the April low point when tariffs freaked everyone out.

But the market needs to find new shiny objects to obsess over.

And I think I know where they are.

Lithium, copper, biotechs and uranium

My big thesis for the next leg of the bull run sits with these four sectors.

Call it the speculative growth trade.

Lithium is my conviction play for 2026.

The US government isn’t messing around anymore. When they get really serious about lithium supply, they’ll need to move fast on a very small group of ASX developers with world-class projects.

Copper? UBS just raised their price target to $11,500 for March 2026. Then $12,000, $12,500, and $13,000 as we move through the year. The structural deficit is real. Demand is set to surge 24% by 2035 and new mine supply can take 17 years from discovery to production.

Uranium is poised at US$75/lb after having two cracks at US$80/lb. I believe it should push towards $90 to $100 by mid-2026 as the AI-nuclear renaissance gathers steam.

And biotechs? The Nasdaq Biotech Index is up ~30% this year. That should filter through to ASX biotechs in the coming months as there are very strong capital markets ties between the two countries in this sector.

Lithium = growth in energy storage

Copper = growth in the global economy + electrification

Biotechs = growth in demand for risk and cashflows that could be a long way off

Uranium = growth in stable energy supply for Big Tech

There may be more geopolitical twists and turns.

The US Fed may starve the market of liquidity and sabotage Trump’s big beautiful stock market bull run.

But the trajectory for these risk-on, speculative growth trade sectors looks better than people think.

And there’s definitely still great value out there if you feel like you missed the rare earths/silver/gold speculative ramp.

I’m not Ray Dalio

Our job in this business is to present alternative viewpoints.

When consensus screams bearish and every talking head predicts doom, someone needs to say: wait a minute.

Dalio says the market is 80% into a bubble.

But even he admits we don’t have the pricking of the bubble yet.

If being a bull in this environment qualifies as an alternative viewpoint right now, then call me a bull.

I’m particularly bullish on the first half of 2026.

The game is always the same. Big funds position first. Media narratives follow. Retail reacts last. And by the time the story is everywhere, the trade is already done.

Maybe, just maybe, the biotech indices yesterday, and the potential floor being put in on the XEC is telling you something the talking heads won’t.

Don’t be the exit liquidity.

Regards,

Lachlann Tierney,
Australian Small-Cap Investigator and Fat Tail Micro-Caps

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Lachlann Tierney
Lachlann ‘Lachy’ Tierney is passionate about uncovering hidden opportunities in the microcap sector. With four years of experience as a senior equities analyst at one of Australia’s leading microcap firms, he has built a reputation for rigorous research, deep-dive due diligence, and accessible investor communications. Over this time, he has vetted seed, pre-IPO and ASX-listed companies across sectors, conducted onsite visits, and built strong relationships across the microcap space. Lachy is nearing completion of a PhD in economics at RMIT University, where his research focuses on blockchain governance and voting systems. His work is housed within the Blockchain Innovation Hub at RMIT, a leading research centre for crypto-economics and blockchain research. He holds a Master’s degree from the London School of Economics and an Honours BA in Philosophy and Politics from the University of Melbourne. Born in New York and raised in California, Lachy grew up a few blocks from biotech giant Amgen and counts among his peers various characters in the overlapping worlds of venture capital, technology and crypto. When he’s not researching microcaps, he’s most likely sweating it out in a sauna or dunking himself in cold Tasmanian water.

Lachlann’s Premium Subscriptions

Publication logo
Australian Small-Cap Investigator
Publication logo
Fat Tail Microcaps
Publication logo
James Altucher’s Early-Stage Crypto Investor Australia

Latest Articles

  • The Bear Conspiracy Pt.2: Not out of the woods…yet
    By Lachlann Tierney

    Speculative ASX stocks may have found a floor. It’s time for cautious optimism near-term, and a look these four sectors going into 2026.

  • Trump’s Supreme Court saved him, but will his Fed?
    By Nick Hubble

    Trump’s appointments to the Supreme Court have saved him from Democrat lawfare. But will the Federal Reserve save him from the bursting AI bubble?

  • The Bear Conspiracy
    By Lachlann Tierney

    Nasdaq Biotech Index rallies 30% as institutional funds reposition. Payment-for-order-flow hits record highs. Why apocalypse narratives might be the real shake-out strategy.

Primary Sidebar

Latest Articles

  • The Bear Conspiracy Pt.2: Not out of the woods…yet
  • Trump’s Supreme Court saved him, but will his Fed?
  • The Bear Conspiracy
  • Flight to Safety: Junior Mining Stocks
  • Forget China (at your peril)

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988